Sign in

CIK 0001826457

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Monte Rosa Therapeutics, Inc.

Sign in to watch
Ticker
GLUE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-949-2643
Business address
321 HARRISON AVENUE, SUITE 900, BOSTON, MA, 02118
Former names
Monte Rosa Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$137
in 1 filing

Net −$137. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Bowen Matthew −$137 Principal Accounting Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2026-06-30 Janku Filip Chief Medical Officer Option exercise 10b5-1 +5,407 $13.41 $73K 66,019
2026-06-30 Janku Filip Chief Medical Officer Sale 10b5-1 −5,407 $24.50 $132K 60,612
2026-06-30 Janku Filip Chief Medical Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −5,407 81,093
2026-06-29 Janku Filip Chief Medical Officer Option exercise 10b5-1 +6,000 $7.56 $45K 65,992
2026-06-29 Janku Filip Chief Medical Officer Sale 10b5-1 −6,000 $22.95 $138K 59,992
2026-06-29 Janku Filip Chief Medical Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −6,000 60,000
2026-06-24 Janku Filip Chief Medical Officer Option exercise 10b5-1 +30,000 $7.56 $227K 89,992
2026-06-24 Janku Filip Chief Medical Officer Sale 10b5-1 −30,000 $21.42 $643K 59,992
2026-06-24 Janku Filip Chief Medical Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −30,000 66,000
2026-06-23 Janku Filip Chief Medical Officer Option exercise 10b5-1 +6,000 $7.56 $45K 71,837
2026-06-23 Janku Filip Chief Medical Officer Sale 10b5-1 −11,845 $20.22 $240K 59,992
2026-06-23 Janku Filip Chief Medical Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −6,000 96,000
2026-02-23 Janku Filip Chief Medical Officer Sale −9,189 $19.50 $179K 65,837
2026-01-05 Janku Filip Chief Medical Officer Sale −3,155 $15.17 $48K 75,026
2026-01-02 Janku Filip Chief Medical Officer Grant or award +31,000 78,181
2026-01-02 Janku Filip Chief Medical Officer Grant or award · Stock Option (Right to Buy) +139,000 139,000
2025-01-02 Janku Filip Chief Medical Officer Grant or award +36,000 45,189
2025-01-02 Janku Filip Chief Medical Officer Grant or award · Stock Option (Right to Buy) +161,000 161,000
2024-09-13 Janku Filip Chief Medical Officer Grant or award · Stock Option (Right to Buy) +30,000 30,000
2024-01-02 Janku Filip Chief Medical Officer Grant or award · Stock Option (Right to Buy) +121,000 121,000

Page 1 of 2 · 25 trades